29-05-2025
Theratechnologies Reports on its Annual Meeting of Shareholders
MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ('Theratechnologies' or the 'Company') (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.
Shareholders proceeded to elect the below candidates to the Company's Board of Directors for a one-year term, appointed KPMG LLP as the Company's auditors for the current fiscal year and approved the adoption of an omnibus long-term incentive plan for the benefits of the directors, executive officers and employees of the Company and those of its subsidiaries.
All candidates proposed for the position of director were elected in the following proportion:
FOR
% FOR
ABSTENTION
% ABSTENTION
Joseph Arena
20,473,944
84.03%
3,890,222
15.97%
Frank Holler
19,089,786
78.35%
5,274,380
21.65%
Paul Lévesque
19,027,772
78.10%
5,336,394
21.90%
Andrew Molson
19,066,145
78.25%
5,298,021
21.75%
Dawn Svoronos
18,998,230
77.98%
5,365,936
22.02%
Elina Tea
19,163,502
78.65%
5,200,664
21.35%
Dale Weil
19,005,768
78.01%
5,358,398
21.99%
Jordan Zwick
19,618,725
80.52%
4,745,441
19.48%
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at on SEDAR+ at and on EDGAR at Follow Theratechnologies on Linkedin and X (formerly Twitter).
Contacts:
Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerpdubuc@
Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@ in to access your portfolio
